The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Small Business Innovation Research (SBIR) Phase I contract to Kephera Diagnostics LLC, a for-profit limited liability company, to develop a biomarker-based test of cure (TOC) to evaluate treatment outcome during the chronic phase of Chagas infection. The contract, a Definitive Contract with Firm Fixed Price pricing, has a potential value of $300,000.00 and a completion date of August 31, 2022. Kephera Diagnostics has prior experience providing in vitro diagnostics and biomarker tests for various neglected infectious diseases through federal grants and contracts.
Generated 3/24/24, 12:02 AM